Rupee against dollar
Check out Techstory’s earnings calendar for the week ahead and our reviews of the most critical reports.
Below is a week-by-week earnings schedule of major upcoming quarterly reports expected to be delivered by public companies by techstory.in. Be that as it may, we have also given outlines of extended benefits for choosing organizations.
MONDAY
Remarkable Earnings Reports
| Company | Symbol | Profit estimate |
| Bank of America | BAC | $0.76 per share |
| Charles Schwab | SCHW | $0.92 |
| Goldman Sachs Group | GS | $6.64 |
| International Business Machines | IBM | $2.27 |
| Prologis | PLD | $0.65 |
| Synchrony Financial | SYF | $1.43 |
TUESDAY
Earnings: Johnson & Johnson
Johnson and Johnson (JNJ, $177.76) is among a modest group of Dow Jones stocks trading in positive territory year-to-date, with shares up around 3.8%.
US Biopharma continues to trade protectively despite broader market unpredictability generally due to strong regional fundamentals, says BofA Global Research expert Geoff Meacham. Of course, even with a pending COVID-19 effect, forex unpredictability and increasing expansion, biopharma has so far borne strong large-scale loads in the first half of 2022.
Meacham adds that JNJ’s second-quarter earnings report, which will be delivered before the July 19 opening, could help set the mood for the region.
All in all, we don’t expect many surprises with JNJ likely to focus on the direction of 2022, with forex headwinds being the biggest swing factor, according to the investigator. As the sections go, it’s buoyant for Pharmaceuticals and Buyers, but hopes to see a drop in revenue for Clinical Gadgets due to continued technical volume items.
Typical reviewer valuations for Johnson and Johnson’s Q2 report include earnings of $2.57 per share, up 3.6% year-over-year (YoY), and revenue of 23.8 billion (+2.2% YoY).
Income: Netflix
Netflix (NFLX, $185.77) has had its fair share of shows in 2022, with shares down more than 69% year-to-date. A key part of those woes came after the web feature’s first-quarter earnings report, when it revealed its most memorable bear woe in more than 10 years.
In any case, in the second quarter, Wedbush pundit Michael Pachter accepts that the NFLX brings less woe to fans than initially feared. It estimates a net streaming deficit of 1.5 million worldwide, against a direction for a net streaming deficit of 2.0 million.
WEDNESDAY
Remarkable Earnings Reports
| Company | Symbol | Profit estimate |
| Abbott Laboratories | ABT | $1.13 per share |
| ASML Company | ASML | $3.81 |
| hugue baker | BKR | $0.22 |
| biogenic | IBIB | $4.13 |
| Comedy | CMA | $1.77 |
| International Crown Castle | ICC | $0.96 |
| CSX | CSX | $0.47 |
| Kinder Morgan | KMI | $0.27 |
| Nasdaq | NDAQ | $1.92 |
| Northern Trust | NTRS | $1.93 |
| PacWest Bancorp | PACW | $1.07 |
| United Airlines Holdings | LAU | $1.82 |
THURSDAY
Remarkable Earnings Reports
| Company | Symbol | Profit estimate |
| ABB | ABB | $0.35 per share |
| Alaska Air Group | ALK | $1.81 |
| American Airlines Group | AAL | $0.76 |
| AT&T | J | $0.61 |
| AutoNation | A | $6.14 |
| DR Horton | DHI | $4.50 |
| Danaher | HRD | $2.36 |
| Dominos Pizza | DPZ | $2.90 |
| Dover | DVV | $1.25 |
| Dow | DOW | $2.14 |
| Fifth Third Bancorp | FITB | $0.87 |
| Intuitive surgery | ISRG | $1.20 |
| KB Financial Group | KB | $2.67 |
| nokia | NOK | $0.09 |
| Nucor | NUDE | $8.26 |
| Philip Morris International | PM | $1.25 |
| Roche Holding | RHBBY | $1.49 |
| SAP | SAP | $1.12 |
| Travelers Cos. | TRV | $1.81 |
FRIDAY
Earnings: Twitter
The way forward is sure to be front and center for backers when Twitter (TWTR, $37.22) releases its second-quarter earnings report ahead of the July 22 open.
Comments are closed.